Position in LH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$889,840
+$118,226 QoQ
Shares Held
3,178
+9.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#482
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Wealthspire Advisors, LLC holds $14,238,925 across 10 Diagnostics & Research names. LH ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,737 | $3,377,662 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
4,941 | $2,601,140 | |
| 3 | DHR |
Danaher Corp /De/
|
12,506 | $2,382,142 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
1,565 | $1,999,303 | |
| 5 | NTRA |
Natera, Inc.
|
5,786 | $1,570,609 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
3,178 | $889,840 | |
| 7 | GH |
Guardant Health, Inc.
|
3,636 | $545,509 | |
| 8 | WAT |
Waters Corp /De/
|
1,020 | $382,540 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $889,840 | 3,178 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $771,614 | 2,892 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $816,614 | 3,255 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $618,327 | 2,154 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $567,284 | 2,161 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $874,404 | 3,757 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $881,506 | 3,844 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $806,986 | 3,611 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $711,470 | 3,496 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||